The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review
Authors
Keywords
-
Journal
Lancet Global Health
Volume 10, Issue 10, Pages e1423-e1442
Publisher
Elsevier BV
Online
2022-09-14
DOI
10.1016/s2214-109x(22)00330-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Availability of diagnostic services and essential medicines for non‐communicable respiratory diseases in African countries
- (2021) C. Plum et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Improving lung health in low-income and middle-income countries: from challenges to solutions
- (2021) Jamilah Meghji et al. LANCET
- Assessing service availability and readiness to manage Chronic Respiratory Diseases (CRDs) in Bangladesh
- (2021) Progga Paromita et al. PLoS One
- Implementation outcomes of national decentralization of integrated outpatient services for severe non‐communicable diseases to district hospitals in Rwanda
- (2021) Simon Pierre Niyonsenga et al. TROPICAL MEDICINE & INTERNATIONAL HEALTH
- Association of Oral Corticosteroid Bursts With Severe Adverse Events in Children
- (2021) Tsung-Chieh Yao et al. JAMA Pediatrics
- Management of chronic lung diseases in Sudan and Tanzania: how ready are the country health systems?
- (2021) Uzochukwu Egere et al. BMC HEALTH SERVICES RESEARCH
- Evaluation of availability, price, and affordability of cardiovascular, diabetes, and global medicines in Abuja, Nigeria
- (2021) Nkeiruka Grace Osuafor et al. PLoS One
- Worldwide trends in the burden of asthma symptoms in school-aged children: Global Asthma Network Phase I cross-sectional study
- (2021) M Innes Asher et al. LANCET
- Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes
- (2021) Helen K. Reddel et al. Journal of Allergy and Clinical Immunology-In Practice
- Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: A nationwide cohort study of the global SABINA programme
- (2020) Bright I. Nwaru et al. EUROPEAN RESPIRATORY JOURNAL
- Accessibility of basic paediatric emergency care in Malawi: analysis of a national facility census
- (2020) Emily White Johansson et al. BMC PUBLIC HEALTH
- Nationwide survey of the availability and affordability of asthma and COPD medicines in Nigeria
- (2020) Obianuju B. Ozoh et al. TROPICAL MEDICINE & INTERNATIONAL HEALTH
- Availability of equipment and medications for non-communicable diseases and injuries at public first-referral level hospitals: a cross-sectional analysis of service provision assessments in eight low-income countries
- (2020) Neil Gupta et al. BMJ Open
- Effect of Novartis Access on availability and price of non-communicable disease medicines in Kenya: a cluster-randomised controlled trial
- (2019) Peter C Rockers et al. Lancet Global Health
- The GOLD Summit on chronic obstructive pulmonary disease in low- and middle-income countries
- (2019) D. M. G. Halpin et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Disparities in availability of essential medicines to treat non-communicable diseases in Uganda: A Poisson analysis using the Service Availability and Readiness Assessment
- (2018) Mari Armstrong-Hough et al. PLoS One
- Impact of economic sanctions on access to noncommunicable diseases medicines in the Islamic Republic of Iran
- (2018) Mehrnaz Kheirandish et al. EASTERN MEDITERRANEAN HEALTH JOURNAL
- Health care costs and resource utilization for different asthma severity stages in Colombia: a claims data analysis
- (2018) Álvaro Flórez-Tanus et al. World Allergy Organization Journal
- Essential medicines for universal health coverage
- (2017) Veronika J Wirtz et al. LANCET
- Baseline assessment of WHO’s target for both availability and affordability of essential medicines to treat non-communicable diseases
- (2017) Margaret Ewen et al. PLoS One
- Access to affordable medicines and diagnostic tests for asthma and COPD in sub Saharan Africa: the Ugandan perspective
- (2017) Davis Kibirige et al. BMC Pulmonary Medicine
- Bronchodilator treatment for COPD in primary care of four Latin America countries: The multinational, cross-sectional, non-interventional PUMA study
- (2016) María Montes de Oca et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Free asthma medications reduces hospital admissions in Brazil (Free asthma drugs reduces hospitalizations in Brazil)
- (2016) Talitha Comaru et al. RESPIRATORY MEDICINE
- A national survey on availability, price and affordability of selected essential medicines for non communicable diseases in Sri Lanka
- (2014) Panthihage Ruvini L Dabare et al. BMC PUBLIC HEALTH
- The Availability, Pricing and Affordability of Three Essential Asthma Medicines in 52 Low- and Middle-Income Countries
- (2013) Zaheer-Ud-Din Babar et al. PHARMACOECONOMICS
- Trends in the use of antiasthmatic medications in Morocco (1999–2010)
- (2013) Imane Ghanname et al. SpringerPlus
- Gaps in Capacity in Primary Care in Low-Resource Settings for Implementation of Essential Noncommunicable Disease Interventions
- (2012) S. Mendis et al. International Journal of Hypertension
- Priority actions for the non-communicable disease crisis
- (2011) Robert Beaglehole et al. LANCET
- Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis
- (2008) A Cameron et al. LANCET
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More